Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
BEKAII-SAAB, Tanios, PHELPS, Mitch A, VASKO, Vasily V, BLOOMSTON, Mark, MARSH, William, AUSTIN DOYLE, L, ELLISON, Gilian, GREVER, Michael, RINGEL, Matthew D, VILLALONA-CALERO, Miguel A, XIAOBAI LI, SAJI, Motoyasu, GOFF, Laura, WOOK KAUH, John Sae, O'NEIL, Bert H, BALSOM, Stephanie, BALINT, Catherine, LIERSEMANN, Ryan
Published in Journal of clinical oncology (10.06.2011)
Published in Journal of clinical oncology (10.06.2011)
Get full text
Journal Article
Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
O'NEIL, Bert H, GOFF, Laura W, SEBTI, Said M, SULLIVAN, Daniel M, WOOK KAUH, John Sae, STROSBERG, Jonathan R, BEKAII-SAAB, Tanios S, LEE, Ruey-Min, KAZI, Aslamuzzaman, MOORE, Dominic T, LEAROYD, Maria, LUSH, Richard M
Published in Journal of clinical oncology (10.06.2011)
Published in Journal of clinical oncology (10.06.2011)
Get full text
Journal Article
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
Ciombor, Kristen K., Feng, Yang, Benson, Al Bowen, Su, Yingjun, Horton, Linda, Short, Sarah P., Kauh, John Sae Wook, Staley, Charles, Mulcahy, Mary, Powell, Mark, Amiri, Katayoun I., Richmond, Ann, Berlin, Jordan
Published in Investigational new drugs (01.10.2014)
Published in Investigational new drugs (01.10.2014)
Get full text
Journal Article
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial
Dowlati, Afshin, Harvey, R. Donald, Carvajal, Richard D., Hamid, Omid, Klempner, Samuel J., Kauh, John Sae Wook, Peterson, Daniel A., Yu, Danni, Chapman, Sonya C., Szpurka, Anna M., Carlsen, Michelle, Quinlan, Tonya, Wesolowski, Robert
Published in Investigational new drugs (01.08.2021)
Published in Investigational new drugs (01.08.2021)
Get full text
Journal Article
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Autio, Karen A, Klebanoff, Christopher A, Schaer, David, Kauh, John Sae Wook, Slovin, Susan F, Adamow, Matthew, Blinder, Victoria S, Brahmachary, Manisha, Carlsen, Michelle, Comen, Elizabeth, Danila, Daniel C, Doman, Thompson N, Durack, Jeremy C, Fox, Josef J, Gluskin, Jill S, Hoffman, David M, Kang, Suhyun, Kang, Praneet, Landa, Jonathan, McAndrew, Philomena F, Modi, Shanu, Morris, Michael J, Novosiadly, Ruslan, Rathkopf, Dana E, Sanford, Rachel, Chapman, Sonya C, Tate, Courtney M, Yu, Danni, Wong, Phillip, McArthur, Heather L
Published in Clinical cancer research (01.11.2020)
Published in Clinical cancer research (01.11.2020)
Get full text
Journal Article
Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study
Autio, Karen A., Klebanoff, Christopher A., Schaer, David, Kauh, John Sae Wook, Slovin, Susan F., Adamow, Matthew, Blinder, Victoria S., Brahmachary, Manisha, Carlsen, Michelle, Comen, Elizabeth, Danila, Daniel C., Doman, Thompson N., Durack, Jeremy C., Fox, Josef J., Gluskin, Jill S., Hoffman, David M., Kang, Suhyun, Kang, Praneet, Landa, Jonathan, McAndrew, Philomena F., Modi, Shanu, Morris, Michael J., Novosiadly, Ruslan, Rathkopf, Dana E., Sanford, Rachel, Chapman, Sonya C., Tate, Courtney M., Yu, Danni, Wong, Phillip, McArthur, Heather L.
Published in Clinical cancer research (26.08.2020)
Published in Clinical cancer research (26.08.2020)
Get full text
Journal Article
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Khalil, Danny N, Postow, Michael A, Ibrahim, Nageatte, Ludwig, Dale L, Cosaert, Jan, Kambhampati, Siva Rama Prasad, Tang, Shande, Grebennik, Dmitri, Kauh, John Sae Wook, Lenz, Heinz-Josef, Flaherty, Keith T, Hodi, F Stephen, Lawrence, Donald P, Wolchok, Jedd D
Published in Clinical cancer research (01.11.2016)
Published in Clinical cancer research (01.11.2016)
Get full text
Journal Article
An Open-label, Dose-Escalation Phase 1 Study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma
Khalil, Danny N., Postow, Michael A., Ibrahim, Nageatte, Ludwig, Dale L., Cosaert, Jan, Kambhampati, Siva Rama Prasad, Tang, Shande, Grebennik, Dmitri, Kauh, John Sae Wook, Lenz, Heinz-Josef, Flaherty, Keith T., Hodi, F. Stephen, Lawrence, Donald P., Wolchok, Jedd D.
Published in Clinical cancer research (19.10.2016)
Published in Clinical cancer research (19.10.2016)
Get full text
Journal Article